INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – TGAN, HMST, KNTE
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating:
- Transphorm, Inc. (Nasdaq: TGAN), relating to its proposed sale to Renesas Electronics Corp. Under the terms of the agreement, TGAN shareholders will receive $5.10 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/transphorm-inc. It is free and there is no cost or obligation to you.
- HomeStreet, Inc. (Nasdaq: HMST), relating to its proposed sale to FirstSun Capital Bancorp. Under the terms of the agreement, HMST shareholders are expected to receive 0.4345 shares of FirstSun common stock per share they own. Click here for more information: https://www.monteverdelaw.com/case/homestreet-inc. It is free and there is no cost or obligation to you.
- Kinnate Biopharma Inc. (Nasdaq: KNTE), relating to its proposed sale to XOMA Corp. Under the terms of the agreement, KNTE shareholders are expected to receive $2.3352 in cash plus an additional cash amount not exceeding $0.2527 per share they own. Click here for more information: https://www.monteverdelaw.com/case/kinnate-biopharma-inc. It is free and there is no cost or obligation to you.
Before you hire a law firm, you should talk to a lawyer and ask:
- Do you recover money for shareholders?
- Do you litigate and go to Court?
- Do you even go to the office and wear a suit?
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits